{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:57:00Z","timestamp":1774544220666,"version":"3.50.1"},"reference-count":61,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2024.j079","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T22:13:09Z","timestamp":1724883189000},"page":"47-58","source":"Crossref","is-referenced-by-count":4,"title":["Lipid-lowering effect of Danshen, Fufang Danshen, Shuxuening and Shuxuetong injections: A Systematic Review and Meta-Analysis of Controlled Clinical Trials"],"prefix":"10.1620","volume":"266","author":[{"given":"Youjin","family":"Zhang","sequence":"first","affiliation":[{"name":"Central Laboratory, Clinical Medical College and Affiliated Hospital of Chengdu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Clinical Medical College and Affiliated Hospital of Chengdu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyin","family":"Pang","sequence":"additional","affiliation":[{"name":"Clinical Medical College of Chengdu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Lv","sequence":"additional","affiliation":[{"name":"Clinical Medical College of Chengdu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Clinical Medical College of Chengdu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Clinical Medical College and Affiliated Hospital of Chengdu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyan","family":"Song","sequence":"additional","affiliation":[{"name":"Central Laboratory, Clinical Medical College and Affiliated Hospital of Chengdu University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alanaeme,C.J., Bittner,V., Brown,T.M., Colantonio,L.D., Dhalwani,N., Jones,J., Kalich,B., Exter,J., Jackson,E.A., Levitan,E.B., Poudel,B., Wang,Z., Woodward,M., Muntner,P. &amp; Rosenson,R.S. (2022) Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA\/ACC multi-society cholesterol guideline. <i>Am. Heart J. Plus<\/i>, 21, 100201.","DOI":"10.1016\/j.ahjo.2022.100201"},{"key":"2","unstructured":"Bian,F., Kang,S., Cui,H., Wang,F. &amp; Luan,T. (2021) The clinical efficacy of compound Danshen injection on acute cerebral infarction and on the changes in the CRP, D-dimer, and IL-6 levels. <i>Am. J. Transl. Res.<\/i>, 13, 8126-8133."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Brown,B.G., Stukovsky,K.H. &amp; Zhao,X.Q. (2006) Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials. <i>Curr. Opin. Lipidol.<\/i>, 17, 631-636.","DOI":"10.1097\/MOL.0b013e32800ff750"},{"key":"4","unstructured":"Chai,S.W., Ge,M.L., Wu,M.X. &amp; He,J. (2023) Study on UPLC fingerprint and content determination of 5 nucleosides in Shuxuetong Injection. <i>Tianjin Journal of Traditional Chinese Medicine<\/i>, 40, 364-370. doi: 10.11656\/j.issn.1672-1519.2023.03.15."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen,H. &amp; Chen,X. (2023) PCSK9 inhibitors for acute coronary syndrome: the era of early implementation. <i>Front. Cardiovasc. Med.<\/i>, 10, 1138787.","DOI":"10.3389\/fcvm.2023.1138787"},{"key":"6","unstructured":"Chen,L.J. (2015) Evaluation of the effect of Danshen injection on treating angina pectoris. <i>Modern Diagnosis and Treatment<\/i>, 26, 3868-3869. doi: CNKI: SUN: XDZD.0.2015-17-020."},{"key":"7","unstructured":"Dong,C.P. &amp; Dong,H. (2016) Analysis on the clinical safety of Shuxuetong injection. <i>Zhong Wai Yi XueYan Jiu<\/i>, 14, 125-126. doi: 10.14033\/j.cnki.cfmr.2016.33.067."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Fan,G., Liu,M., Liu,J., Chen,X. &amp; Huang,Y. (2022) Systematic Review of the Efficacy and Safety of Shuxuening Injection in the Treatment of Unstable Angina. <i>Evid. Based Complement. Alternat. Med.<\/i>, 2022, 6650763.","DOI":"10.1155\/2022\/6650763"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Galema-Boers,A.M.H., Mulder,J., Steward,K. &amp; Roeters van Lennep,J.E. (2023) Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry. <i>Atherosclerosis<\/i>, 384, 117108.","DOI":"10.1016\/j.atherosclerosis.2023.03.013"},{"key":"10","unstructured":"Geng,Q.X., Zhu,X.L. &amp; Zhang,X.H. (2004) Effect of combined therapy of shenmai and compound danshen injection on myocardial reperfusion injury after percutaneous coronary intervention in patients with acute myocardial infarction. <i>Zhongguo Zhong Xi Yi Jie He Za Zhi<\/i>, 24, 496-499."},{"key":"11","unstructured":"Gong, T. &amp; Shang, B. (2023) Reasonability and safety evaluation in the use of Shuxuening injection. <i>Hai Jun Yi Xue Za Zhi<\/i>, 44, 524-526. doi: 10.3969\/j.issn.1009-0754.2023.05.023."},{"key":"12","unstructured":"Gong, Y.X. (2011) Clinical efficacy of Danshen injection in the treatment of acute coronary syndrome. <i>Lin Chuang He Li Yong Yao Za Zhi<\/i>, 4, 44-45. doi: 10.15887\/j.cnki.13-1389\/r.2011.27.006."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Grundy, S.M., Stone, N.J., Bailey, A.L., Beam, C., Birtcher, K.K., Blumenthal, R.S., Braun, L.T., de Ferranti, S., Faiella-Tommasino, J., Forman, D.E., Goldberg, R., Heidenreich, P.A., Hlatky, M.A., Jones, D.W., Lloyd-Jones, D., et al. (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>Circulation<\/i>, 139, e1082-e1143.","DOI":"10.1161\/CIR.0000000000000624"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Guo, J.N., Bai, X., Zhang, H.X., Zhang, N., Liang, J.M., Guo, Z.Y. &amp; Cui, X. (2022) Efficacy and safety of Chinese herbal medicine for pneumonia convalescence in children: A systematic review and meta-analysis. <i>Front. Pharmacol.<\/i>, 13, 956736.","DOI":"10.3389\/fphar.2022.956736"},{"key":"15","unstructured":"He, X.Y., Zheng, F.S. &amp; Huang, J.Y. (2014) Clinical observation of Shuxuening injection combined with Rosuvastatin on unstable angina. <i>Zhong Guo Xian Dai Ying Yong Yao Xue<\/i>, 31, 606-609. doi: 10.13748\/j.cnki.issn1007-7693.2014.05.024."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ho, W.Y., Yen, C.L., Lee, C.C., Tu, Y.R., Chen, C.Y., Hsiao, C.C., Chu, P.H., Hsu, H.H., Tian, Y.C. &amp; Chang, C.H. (2022) Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study. <i>Front. Cardiovasc. Med.<\/i>, 9, 907539.","DOI":"10.3389\/fcvm.2022.907539"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Huang, S.Y., Cui, H.S., Lyu, M.S., Huang, G.R., Hou, D. &amp; Yu, M.X. (2022) Efficacy of traditional Chinese medicine injections for treating idiopathic pulmonary fibrosis: A systematic review and network meta-analysis. <i>PLoS One<\/i>, 17, e0272047.","DOI":"10.1371\/journal.pone.0272047"},{"key":"18","unstructured":"Huang, X.F., Wang, J.M., Chen, Q., Wei, Y.Y. &amp; Chen, H.W. (2015) Meta-analysis on effect of compound Danshen injection in treating neonatal hypoxic-ischemic encephalopathy. <i>Zhongguo Zhong Yao Za Zhi<\/i>, 40, 141-148."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Iatan, I., Mancini, G.B.J., Yeoh, E. &amp; Hegele, R.A. (2023) Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management. <i>Expert Rev. Cardiovasc. Ther.<\/i>, 21, 423-435.","DOI":"10.1080\/14779072.2023.2215982"},{"key":"20","unstructured":"Jiang, J.J., Xie, Y.M., Zhang, Y., Zhang, Y.K., Wang, Z.M. &amp; Han, B. (2016) Clinical medication characteristics of Shuxuening injection in treatment of cerebral infarction research based on registration. <i>Zhongguo Zhong Yao Za Zhi<\/i>, 41, 4516-4520."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Li, C.M., Dong, X.L., Fan, X.D., Wu, J.H., Wang, Q.H., Tian, X.L., Guo, D.J., Wong, M.S., Qiu, T.Q. &amp; Chan, S.W. (2013)  Aqueous extract of danshen (Salvia miltiorrhiza Bunge) protects ovariectomized rats fed with high-fat diet from endothelial dysfunction.  <i>Menopause<\/i>, 20, 100-109.","DOI":"10.1097\/gme.0b013e31825b512d"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Li, H.Q., Wei, J.J., Xia, W., Li, J.H., Liu, A.J., Yin, S.B., Wang, C., Song, L., Wang, Y., Zheng, G.Q. &amp; Fan, J.P. (2015)  Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: a systematic review and meta-analysis.  <i>Acta. Pharmacol. Sin.<\/i>, 36, 659-675.","DOI":"10.1038\/aps.2014.139"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Li, L.D., Zhou, Y. &amp; Shi, S.F. (2023a)  Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis.  <i>Medicine (Baltimore)<\/i>, 102, e32929.","DOI":"10.1097\/MD.0000000000032929"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Li, M., Li, H., Liu, H., Lai, X. &amp; Xing, W. (2022a)  Efficacy and safety of eight types Salvia miltiorrhiza injections in the treatment of unstable angina pectoris: A network meta-analysis.  <i>Front. Pharmacol.<\/i>, 13, 972738.","DOI":"10.3389\/fphar.2022.972738"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Li, S., He, C., Nie, H., Pang, Q., Wang, R., Zeng, Z. &amp; Song, Y. (2022b)  G Allele of the rs1801282 Polymorphism in PPARgamma Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis.  <i>Front. Endocrinol. (Lausanne)<\/i>, 13, 919087.","DOI":"10.3389\/fendo.2022.919087"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Li, S., Zhang, Y., Xu, W., Lv, Z., Xu, L., Zhao, Z., Zhu, D. &amp; Song, Y. (2023b)  C Allele of the PPARdelta+294T&gt;C Polymorphism Confers a Higher Risk of Hypercholesterolemia, but not Obesity and Insulin Resistance: A Systematic Review and Meta-Analysis.  <i>Horm. Metab. Res.<\/i>, 55, 355-366.","DOI":"10.1055\/a-2043-7707"},{"key":"27","unstructured":"Li, S.Y. (2012)  Re-evaluation on safety and efficacy of Xiangdan injection for treating the syndrome of qi deficiency and blood stasis.  <i>Zhong Guo Shi Yan Fang Ji Xue Za Zhi<\/i>, 18, 318-320. doi: 10.13422\/j.cnki.syfjx.2012.21.050."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Liu, Y., Huang, Y., Zhao, C., Qin, X., Zhu, Q., Chen, S. &amp; Qu, J. (2014)  Salvia miltiorrhiza injection on pulmonary heart disease: a systematic review and meta-analysis.  <i>Am. J. Chin. Med.<\/i>, 42, 1315-1331.","DOI":"10.1142\/S0192415X14500827"},{"key":"29","unstructured":"Liu, Y. &amp; Wang, J. (2021)  Effect of rosuvastatin calcium tablets combined with Shuxuetong injection on blood lipid indexes and inflammatory factor levels in elderly patients with acute cerebral infarction.  <i>Lin Chuang Yi Xue Yan Jiu Yu Shi Jian<\/i>, 6, 67-69. doi: 10.19347\/j.cnki.2096-1413.202136021."},{"key":"30","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(2002)  Third Report of the National Cholesterol Education Program (NCEP)  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.  <i>Circulation<\/i>, 106, 3143-3421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"31","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell, M.J., Chin, S.L., Rangarajan, S., Xavier, D., Liu, L., Zhang, H., Rao-Melacini, P., Zhang, X., Pais, P., Agapay, S., Lopez-Jaramillo, P., Damasceno, A., Langhorne, P., McQueen, M.J., Rosengren, A., et al.  (2016) Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. <i>Lancet<\/i>, 388, 761-775.","DOI":"10.1016\/S0140-6736(16)30506-2"},{"key":"32","doi-asserted-by":"crossref","unstructured":"P\u00e1l, E., Ungvari, Z., Benyo, Z. &amp; Varbiro, S. (2023) Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases. <i>Nutrients<\/i>, 15, 334.","DOI":"10.3390\/nu15020334"},{"key":"33","unstructured":"Pan, E. (2020) Safety evaluation and clinical rational use of Xiangdan injection. <i>Zhong Xi Yi Jie He Xin Xue Guan Bing Dian Zi Za Zhi<\/i>, 8, 165-166. doi: 10.16282\/j.cnki.cn11-9336\/r.2020.17.125."},{"key":"34","unstructured":"Pu, K.J. (2009) Clinical observation of Xiangdan injection combined with Lovastatin in the treatment of impaired glucose tolerance with Dyslipidemia. <i>Lin Chuang He Li Yong Yao Za Zhi<\/i>, 2, 46-47. doi: 10.15887\/j.cnki.13-1389\/r.2009.22.069."},{"key":"35","unstructured":"Qu, Y., Ma, X.J., Li, Q.H., Li, H.L., Zhao, X.C., Sun, X.H., Zhang, M. &amp; Chen, H. (2023) Intensive hospital monitoring study on safety of 9735 cases of Shuxuening injection. <i>Zhong Cao Yao<\/i>, 54, 3253-3260. doi: 10.7501\/j.issn.0253-2670.2023.10.022."},{"key":"36","unstructured":"Ren, P., Cao, L., Zhao, X.K., Zhu, B.B. &amp; Liu, K. (2022) Network Meta-analysis of Chinese medicine injections in treatment of hypertensive intracerebral hemorrhage. <i>Zhongguo Zhong Yao Za Zhi<\/i>, 47, 3637-3647."},{"key":"37","doi-asserted-by":"crossref","unstructured":"Shao, H., Li, M., Chen, F., Chen, L., Jiang, Z. &amp; Zhao, L. (2018) The Efficacy of Danshen Injection as Adjunctive Therapy in Treating Angina Pectoris: A Systematic Review and Meta-Analysis. <i>Heart Lung Circ.<\/i>, 27, 433-442.","DOI":"10.1016\/j.hlc.2017.10.016"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Shen, H., Zhou, P., Shen, L., Ju, C., Du, H. &amp; Qu, X. (2022) Effectiveness and safety of selected traditional Chinese medicine injections in patients with combined diabetes mellitus and coronary heart disease: A systematic review and network meta-analysis of randomized clinical trials. <i>Front. Pharmacol.<\/i>, 13, 1060956.","DOI":"10.3389\/fphar.2022.1060956"},{"key":"39","unstructured":"Song, L.G., Wang, Q. &amp; Bai, H.P. (2009) Safety evaluation and rational use of Xiangdan injection. <i>Zhong Guo Shi Ping Yao Ping Jian Guan<\/i>, 12, 72-73. doi: CNKI: SUN: YPJD.0.2009-06-043."},{"key":"40","doi-asserted-by":"crossref","unstructured":"Su, M., Jia, A., He, Y. &amp; Song, Y. (2021) Associations of the Polymorphisms in ADIPOQ with Circulating Levels of Adiponectin and Lipids: A Meta-Analysis. <i>Horm. Metab. Res.<\/i>, 53, 541-561.","DOI":"10.1055\/a-1543-6362"},{"key":"41","unstructured":"Tan, D., Wu, J., Liu, S., Zhang, D., Cui, Y., Zhang, X. &amp; Zhang, B. (2018)  Injections of ginkgo in the treatment of cerebral infarction: a systematic review and network Meta-analysis.  <i>J. Tradit. Chin. Med.<\/i>, 38, 1-11."},{"key":"42","unstructured":"Tong, C.X., Xing, X.F. &amp; Qiao, S.H. (2012)  Clinical effectiveness assessment of compound danshen injection on early onset severe preeclampsia patients.  <i>Zhongguo Zhong Xi Yi Jie He Za Zhi<\/i>, 32, 482-485. doi: CNKI: SUN: ZZXJ.0.2012-04-018."},{"key":"43","doi-asserted-by":"crossref","unstructured":"Tsao, C.W., Aday, A.W., Almarzooq, Z.I., Anderson, C.A.M., Arora, P., Avery, C.L., Baker-Smith, C.M., Beaton, A.Z., Boehme, A.K., Buxton, A.E., Commodore-Mensah, Y., Elkind, M.S.V., Evenson, K.R., Eze-Nliam, C., Fugar, S., et al.  (2023)  Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.  <i>Circulation<\/i>, 147, e93-e621.","DOI":"10.1161\/CIR.0000000000001123"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Tsu, L.V., Carroll, K., Kindler, K. &amp; Early, N. (2021)  Pharmacological Management of Hyperlipidemia in Older individuals.  <i>Sr. Care Pharm.<\/i>, 36, 284-303.","DOI":"10.4140\/TCP.n.2021.284"},{"key":"45","doi-asserted-by":"publisher","unstructured":"Wang, M. &amp; Zhang, J. (2012)  The correlation between the quality process and medication safety of Shuxuetong injection.  <i>Zhong Guo Zhong Yao Za Zhi<\/i>, 37, 2818-2819. doi: 10.4268\/cjcmm20121837.","DOI":"10.4268\/cjcmm20121837"},{"key":"46","unstructured":"Wang, Y.Q., Guo, W.Q., Liu, X.X., Xiao, H.B., Niu, W.Y. &amp; Li, F.J. (2022)  Effect of Danshen injection on lipid metabolism in hyperlipidemia model mice.  <i>Hu Nan Zhong Yi Yao Xue Bao<\/i>, 42, 911-916. doi: 10.3969\/j.issn.1674-070X.2022.06.007."},{"key":"47","unstructured":"Wang, Z.Q. (2013)  Analysis of the therapeutic effect of Danshen injection on 50 cases with angina pectoris.  <i>Da Jia Jian Kang<\/i>, 7, 15. doi: CNKI: SUN: JKXS.0.2013-05-014."},{"key":"48","unstructured":"Weng, M.L. &amp; Han, Y. (2012)  Safe application of Danshen Injection.  <i>Zhong Guo Shi Yan Fang Ji Xue Za Zhi<\/i>, 18, 322-324. doi: 10.13422\/j.cnki.syfjx.2012.22.048."},{"key":"49","doi-asserted-by":"crossref","unstructured":"Wu, S.D., Wang, J., Chen, S.C., Xu, J.B., Zheng, Q., Yan, Y.F., Wen, T.M. &amp; Tang, Y.R. (2004)  Effect of Xiangdan Injection on mRNA expression of endothelial vaso-active factors of patients with coronary heart disease and blood stasis.  <i>Zhong Xi Yi Jie He Xue Bao<\/i>, 2, 94-96.","DOI":"10.3736\/jcim20040205"},{"key":"50","unstructured":"Xie, Y.Q. &amp; Yang, X.S. (2004)  Clinical evaluation of Shuxuening injection in the treatment of acute cerebral infarction.  <i>Yi Xue Lin Chuang Yan Jiu<\/i>, 21, 185-187. doi: 10.3969\/j.issn.1671-7171.2004.02.035."},{"key":"51","unstructured":"Xu, X.M., Lai, S.Z., Tan, B.R., Xu, W.G., Fang, P.S. &amp; Guo, J.Y. (2010) Preliminary safety evaluation of Salvia Miltiorrhiza injection in its clinical application. <i>Zhong Guo Xian Dai Ying Yong Yao Xue<\/i>, 27, 753-756. doi: CNKI: SUN: XDYD.0.2010-08-029."},{"key":"52","unstructured":"Yang, L., Wang, Y.C., Du, X.X., Ren, J.T., Song, H.B. &amp; Liu, X.D. (2013) Post-marketing safety literature analysis and risk control recommendations of Shuxuening injection. <i>Zhong Guo Yao Wu Jing Jie<\/i>, 10, 553-556. doi: 10.3969\/j.issn.1672-8629.2013.09.012."},{"key":"53","unstructured":"Yang, W. &amp; Xie, Y.M. (2014) Safety researches and risk minimization action plan of Shu xue ning injection. <i>Shi Jie Zhong Yi Yao<\/i>, 9, 1128-1132. doi: 10.3969\/j.issn.1673-7202.2014.09.005."},{"key":"54","doi-asserted-by":"crossref","unstructured":"Yu, H., Han, M., Lin, W., Wang, L., Liu, P., Yang, K., Pei, M. &amp; Yang, H. (2020) Efficacy of Chinese Herbal Injections for the Treatment of Primary Nephrotic Syndrome: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. <i>Front. Pharmacol.<\/i>, 11, 579241.","DOI":"10.3389\/fphar.2020.579241"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Yu, L., Zhou, C., Luo, Z., Zeng, W., Lai, F., Han, G. &amp; Song, Y. (2018) The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials. <i>Lipids Health Dis.<\/i>, 17, 106.","DOI":"10.1186\/s12944-018-0760-2"},{"key":"56","unstructured":"Yu, W., Shen, F. &amp; Ma, Z. (2000) Observation of therapeutic effect of Salviae miltiorrhiza and cytosine diphosphate-choline injection on patients with hypertensive cerebral hemorrhage. <i>Zhongguo Zhong Xi Yi Jie He Za Zhi<\/i>, 20, 94-96."},{"key":"57","doi-asserted-by":"crossref","unstructured":"Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L. &amp; INTERHEART Study Investigators(2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. <i>Lancet<\/i>, 364, 937-952.","DOI":"10.1016\/S0140-6736(04)17018-9"},{"key":"58","unstructured":"Zhang, L.Y., Wang, X.X. &amp; Yang, J.Y. (2003) New exploration in the mechanism of Ginkgo leaf extract regulating lipid. <i>Zhong Guo Wei Sheng Tai Xue Za Zhi<\/i>, 15, 342-344. doi: 10.3969\/j.issn.1005-376X.2003.06.014."},{"key":"59","unstructured":"Zhou, X.F. (2017) Effects of Xiang dan injection combined with Trimetazidine tablets for angina pectoris and influences on the levels of inflammatory factors. <i>Ji Lin Zhong Yi Yao<\/i>, 37, 788-791. doi: 10.13463\/j.cnki.jlzyy.2017.08.009."},{"key":"60","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Chen, H., Shen, Y. &amp; Huang, H. (2022) Chinese Herb Injections in the Adjuvant Treatment for Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials. <i>Evid. Based Complement. Alternat. Med.<\/i>, 2022, 3166416.","DOI":"10.1155\/2022\/3166416"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Zivkovic, S., Maric, G., Cvetinovic, N., Lepojevic-Stefanovic, D. &amp; Bozic Cvijan, B. (2023) Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements-A Narrative Review. <i>Nutrients<\/i>, 15, 1517.","DOI":"10.3390\/nu15061517"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/1\/266_2024.J079\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:40:34Z","timestamp":1748061634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/1\/266_2024.J079\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j079","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024.J079"}}